BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35390742)

  • 1. Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction.
    Sabol HM; Amorim T; Ashby C; Halladay D; Anderson J; Cregor M; Sweet M; Nookaew I; Kurihara N; Roodman GD; Bellido T; Delgado-Calle J
    Neoplasia; 2022 Jun; 28():100785. PubMed ID: 35390742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
    Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
    Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
    Canalis E; Zanotti S; Schilling L; Eller T; Yu J
    J Biol Chem; 2021; 296():100583. PubMed ID: 33774049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma.
    Sabol HM; Ashby C; Adhikari M; Anloague A; Kaur J; Khan S; Choudhury SR; Schinke C; Palmieri M; Barnes CL; Ambrogini E; Nookaew I; Delgado-Calle J
    Haematologica; 2024 Feb; ():. PubMed ID: 38385272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
    Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
    Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of sophocarpine triflorohydrazone and its proliferation inhibition and apoptosis induction activity in myeloma cells through Notch3-p53 signaling activation.
    Wang Y; Li W; Huang F; Wu X; Chen W; Dong M; Zhou J
    Environ Toxicol; 2021 Apr; 36(4):484-490. PubMed ID: 33156571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte CIITA aggravates osteolytic bone lesions in myeloma.
    Liu H; He J; Bagheri-Yarmand R; Li Z; Liu R; Wang Z; Bach DH; Huang YH; Lin P; Guise TA; Gagel RF; Yang J
    Nat Commun; 2022 Jun; 13(1):3684. PubMed ID: 35760800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.
    Sabol HM; Ferrari AJ; Adhikari M; Amorim T; McAndrews K; Anderson J; Vigolo M; Lehal R; Cregor M; Khan S; Cuevas PL; Helms JA; Kurihara N; Srinivasan V; Ebetino FH; Boeckman RK; Roodman GD; Bellido T; Delgado-Calle J
    Cancer Res; 2021 Oct; 81(19):5102-5114. PubMed ID: 34348968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy.
    Toscani D; Bolzoni M; Ferretti M; Palumbo C; Giuliani N
    Front Immunol; 2018; 9():2467. PubMed ID: 30410490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.
    Giuliani N; Ferretti M; Bolzoni M; Storti P; Lazzaretti M; Dalla Palma B; Bonomini S; Martella E; Agnelli L; Neri A; Ceccarelli F; Palumbo C
    Leukemia; 2012 Jun; 26(6):1391-401. PubMed ID: 22289923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways.
    Ormsby RT; Solomon LB; Yang D; Crotti TN; Haynes DR; Findlay DM; Atkins GJ
    Acta Biomater; 2019 Mar; 87():296-306. PubMed ID: 30690207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling drives multiple myeloma induced osteoclastogenesis.
    Colombo M; Thümmler K; Mirandola L; Garavelli S; Todoerti K; Apicella L; Lazzari E; Lancellotti M; Platonova N; Akbar M; Chiriva-Internati M; Soutar R; Neri A; Goodyear CS; Chiaramonte R
    Oncotarget; 2014 Nov; 5(21):10393-406. PubMed ID: 25257302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lateral meningocele syndrome mutation causes marked osteopenia in mice.
    Canalis E; Yu J; Schilling L; Yee SP; Zanotti S
    J Biol Chem; 2018 Sep; 293(36):14165-14177. PubMed ID: 30042232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
    Hubmann R; Schnabl S; Araghi M; Schmidl C; Rendeiro AF; Hilgarth M; Demirtas D; Ali F; Staber PB; Valent P; Zielinski C; Jäger U; Shehata M
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.
    Zhang Z; Wang H; Ikeda S; Fahey F; Bielenberg D; Smits P; Hauschka PV
    Am J Pathol; 2010 Sep; 177(3):1459-69. PubMed ID: 20651241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
    Yang J; He J; Wang J; Cao Y; Ling J; Qian J; Lu Y; Li H; Zheng Y; Lan Y; Hong S; Matthews J; Starbuck MW; Navone NM; Orlowski RZ; Lin P; Kwak LW; Yi Q
    Leukemia; 2012 Sep; 26(9):2114-23. PubMed ID: 22425892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of osteocytes in multiple myeloma bone disease.
    Delgado-Calle J; Bellido T; Roodman GD
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):407-13. PubMed ID: 25289928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the role of connexin 43-mediated intercellular communication in the process of intracortical bone resorption via osteocytic osteolysis.
    Lloyd SA; Loiselle AE; Zhang Y; Donahue HJ
    BMC Musculoskelet Disord; 2014 Apr; 15():122. PubMed ID: 24716486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jagged1 promotes mineralization in human bone-derived cells.
    Osathanon T; Manokawinchoke J; Sa-Ard-Iam N; Mahanonda R; Pavasant P; Suwanwela J
    Arch Oral Biol; 2019 Mar; 99():134-140. PubMed ID: 30682716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.